PGK1 and central nervous system cancer: Taken together, this study is the first to report that the neurogenic compound P7C3 exhibits an inhibitory effect on malignant growth of glioma in vitro and in vivo, possibly due to its effect on the glycolytic pathway, specifically on PGK1, as the direct target of P7C3 in glioma cells.